Ignite Creation Date:
2024-05-06 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04716634
Status:
COMPLETED
Last Update Posted:
2024-03-25
First Post:
2021-01-13
Brief Title:
Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors
Sponsor:
BeiGene
Organization:
BeiGene
Organization Data
Organization:
BeiGene
Class:
INDUSTRY
Study ID:
BGB-A317-fruquintinib-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BeiGene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hutchison Medipharma Limited | INDUSTRY |